Solvay Pharmaceuticals, Inc.
92 articles about Solvay Pharmaceuticals, Inc.
-
Solvay Pharmaceuticals, Inc. Scratches Plan for $300 Million Birmingham Plant
10/1/2008
-
Solvay Pharmaceuticals, Inc. Announces 40 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM)
9/15/2008
-
Solvay Pharmaceuticals, Inc. Raises Innogenetics Bid, Beats off Gen-Probe Incorporated
7/9/2008
-
Solvay Pharmaceuticals, Inc. New Subset Analysis of AndroGel(R) Data Highlights Efficacy
6/18/2008
-
Dr. Stephen Hill Named to PhRMA Board of Directors
5/6/2008
-
Wyeth Ends Collaboration Agreements with Solvay Pharmaceuticals, Inc. for Bifeprunox and Other Compounds
2/29/2008
-
FDA Approves Jazz Pharmaceuticals, Inc.'s Luvox(R) CR Extended-Release Capsules for the Treatment of Social Anxiety Disorder and Obsessive Compulsive Disorder
2/29/2008
-
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S.FDA for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
2/19/2008
-
Solvay Pharmaceuticals, Inc. Announces New President and CEO
1/31/2008
-
Pharming Group Starts Collaboration with Solvay and Academic Groups on Parkinson and Alzheimer Disease
12/17/2007
-
Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
12/13/2007
-
Solvay Pharmaceuticals, Inc. Awards 100 College Scholarships to Students with Cystic Fibrosis
10/16/2007
-
Bionas GmbH Signs Service Contract with Solvay Pharmaceuticals, Inc.
10/1/2007
-
Solvay Pharmaceuticals, Inc. Announces FDA Extension of Tedisamil PDUFA Date
9/26/2007
-
Gene Logic Inc. and Solvay Pharmaceuticals, Inc. Enter Agreement to Discover New Development Paths for Multiple Clinical Drug Candidates
8/27/2007
-
FDA Deems Wyeth (Jobs) and Solvay Pharmaceuticals, Inc. Schizophrenia Drug Not Approvable
8/10/2007
-
Jazz Pharmaceuticals, Inc. (Jobs) Says Solvay Pharmaceuticals, Inc. Gives FDA More Luvox Information
8/3/2007
-
Solvay Pharmaceuticals, Inc.'s Operating Results of EUR 616 Million for the 1st Half of 2007, Exceeding the Excellent Results for the 1st half of 2006
7/27/2007
-
Solvay Pharmaceuticals, Inc. Announces Submission of Supplemental New Drug Application for AndroGel(R) in Male Adolescents
6/14/2007
-
Solvay Pharmaceuticals, Inc. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects vs. Placebo in Stabilized Patients with Schizophrenia
5/23/2007